The Asia Pacific breast implants market is expected to reach US$ 445.65 million by 2027 from US$ 287.32 million in 2019. The market is estimated to grow at a CAGR of 5.8% from 2020 to 2027.
The growth of the Asia Pacific breast implants market can be attributed to factors such as increasing incidence rates of breast cancer in Asia Pacific and rise in breast augmentation procedures in Asian countries. On the other hand, the market is likely to have negative impact due to risks associated with breast implants such as breast pain and infection.
With the rapid economic development in Asia Pacific, demand for cosmetic surgery has increased rapidly. Breast augmentation is the most common cosmetic procedure performed in Asia. Increase in breast cosmetic procedures in Asia has been observed due to aesthetic reasons.
As per the 2018 report by the International Society of Aesthetic Plastic Surgery, 895,896 cosmetic procedures were performed in India, of which, 31,602 were breast augmentation procedures and 1,886 were breast implant removal procedures. Similarly, total number of cosmetic procedures in Australia was 202,642, of which, 17,553 were breast augmentation procedures. Additionally, in Thailand 140,123 total cosmetic procedures were performed, of which, 17,048 were breast augmentation procedures.
Thus, growing number of breast cosmetic surgeries in the Asia Pacific countries is anticipated to fuel the growth of the breast implants market.
Based on product, the Asia Pacific breast implants market is segmented into silicone and saline. In 2019, the silicone segment held the largest share of the market. The segment is expected to grow at the fastest rate during the forecast period. In terms of application, the Asia Pacific breast implants market is segmented into cosmetic surgery and reconstructive surgery. The cosmetic surgery segment accounted for the largest share of the market in 2019. The segment is expected to grow at the fastest rate during the forecast period owing to lower rate of infection or complications. Based on surface type, the market is categorized into smooth and textured. The smooth segment held the largest share of the market in 2019. It is anticipated to grow at the fastest rate during the forecast period.
A few major secondary sources for Asia Pacific breast implants market included in the report are International Society of Aesthetic Plastic Surgery, Cancer Australia, WHO Globocan, National Institute of Cancer Prevention and Research (NICPR), Institute of Indian Council of Medical Research (ICMR), and National Cancer Screening Program (NCSP), among others.
The growth of the Asia Pacific breast implants market can be attributed to factors such as increasing incidence rates of breast cancer in Asia Pacific and rise in breast augmentation procedures in Asian countries. On the other hand, the market is likely to have negative impact due to risks associated with breast implants such as breast pain and infection.
With the rapid economic development in Asia Pacific, demand for cosmetic surgery has increased rapidly. Breast augmentation is the most common cosmetic procedure performed in Asia. Increase in breast cosmetic procedures in Asia has been observed due to aesthetic reasons.
As per the 2018 report by the International Society of Aesthetic Plastic Surgery, 895,896 cosmetic procedures were performed in India, of which, 31,602 were breast augmentation procedures and 1,886 were breast implant removal procedures. Similarly, total number of cosmetic procedures in Australia was 202,642, of which, 17,553 were breast augmentation procedures. Additionally, in Thailand 140,123 total cosmetic procedures were performed, of which, 17,048 were breast augmentation procedures.
Thus, growing number of breast cosmetic surgeries in the Asia Pacific countries is anticipated to fuel the growth of the breast implants market.
Based on product, the Asia Pacific breast implants market is segmented into silicone and saline. In 2019, the silicone segment held the largest share of the market. The segment is expected to grow at the fastest rate during the forecast period. In terms of application, the Asia Pacific breast implants market is segmented into cosmetic surgery and reconstructive surgery. The cosmetic surgery segment accounted for the largest share of the market in 2019. The segment is expected to grow at the fastest rate during the forecast period owing to lower rate of infection or complications. Based on surface type, the market is categorized into smooth and textured. The smooth segment held the largest share of the market in 2019. It is anticipated to grow at the fastest rate during the forecast period.
A few major secondary sources for Asia Pacific breast implants market included in the report are International Society of Aesthetic Plastic Surgery, Cancer Australia, WHO Globocan, National Institute of Cancer Prevention and Research (NICPR), Institute of Indian Council of Medical Research (ICMR), and National Cancer Screening Program (NCSP), among others.
Table of Contents
1. Introduction
3. Research Methodology
4. Asia Pacific Breast Implants Market Landscape
5. Asia Pacific Breast Implants Market Key Market Dynamics
6. Breast Implants Market - Asia Pacific Analysis
7. Breast Implants Market Analysis - By Product
8. Breast Implants Market Analysis - By Application
9. Breast Implants Market Analysis -By Surface Type
10. Breast Implants Market Revenue and Forecasts To 2027 - Country Analysis
11. Impact of COVID-19 Pandemic on Global Breast Implants Market
12. Company Profiles
13. Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Mentor Worldwide Llc
- POLYTECH Health & Aesthetics Gmbh
- Groupe Sebbin Sas
- Guangzhou Wanhe Plastic Materials Co., Ltd.
- Allergan Plc
